Found: 5
Select item for more details and to access through your institution.
Neuroprotective Effects of Cryptotanshinone in a Direct Reprogramming Model of Parkinson's Disease.
- Published in:
- Molecules, 2020, v. 25, n. 16, p. 3602, doi. 10.3390/molecules25163602
- By:
- Publication type:
- Article
Iroquois Homeobox Protein 2 Identified as a Potential Biomarker for Parkinson's Disease.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 10, p. 3455, doi. 10.3390/ijms21103455
- By:
- Publication type:
- Article
Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21<sup>WAF1/CIP1</sup> expression.
- Published in:
- Molecular Brain, 2015, v. 8, n. 1, p. 1, doi. 10.1186/s13041-015-0145-7
- By:
- Publication type:
- Article
LRRK2 impairs autophagy by mediating phosphorylation of leucyl‐tRNA synthetase.
- Published in:
- Cell Biochemistry & Function, 2018, v. 36, n. 8, p. 431, doi. 10.1002/cbf.3364
- By:
- Publication type:
- Article
Quantitative Proteomic Analysis of Primitive Neural Stem Cells from LRRK2 G2019S-Associated Parkinson's Disease Patient-Derived iPSCs.
- Published in:
- Life (2075-1729), 2020, v. 10, n. 12, p. 331, doi. 10.3390/life10120331
- By:
- Publication type:
- Article